Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer have?
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer has 5,365 citations in the OpenAlex counts ScholarIQ stores.
When was Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer published?
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer has 2005 year in the ScholarIQ index.
What is the open-access status of Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer?
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer?
The DOI for Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer is on the source record.
What is the PMID of Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer?
The PMID for Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer is on the source record.
What is the OpenAlex record for Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer?
The OpenAlex for Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer is on the source record.